{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:23:39Z","timestamp":1793298219522,"version":"4.5.0"},"reference-count":135,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research (RFBR)","doi-asserted-by":"publisher","award":["18-29-01009"],"award-info":[{"award-number":["18-29-01009"]}],"id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virus Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.virusres.2018.08.012","type":"journal-article","created":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T17:10:51Z","timestamp":1534525851000},"page":"40-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX"],"prefix":"10.1016","volume":"257","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3821-6846","authenticated-orcid":false,"given":"Aleksei A.","family":"Stepanenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir P.","family":"Chekhonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virusres.2018.08.012_bib0005","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1182\/blood-2009-03-208835","article-title":"Identification of coagulation factor (F)X binding sites on the adenovirus serotype 5 hexon: effect of mutagenesis on FX interactions and gene transfer","volume":"114","author":"Alba","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.virusres.2018.08.012_bib0010","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/mt.2015.194","article-title":"Development of novel adenoviral vectors to overcome challenges observed with HAdV-5-based constructs","volume":"24","author":"Alonso-Padilla","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0015","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0042-6822(03)00238-1","article-title":"Shortening adenovirus type 5 fiber shaft decreases the efficiency of postbinding steps in CAR-expressing and nonexpressing cells","volume":"312","author":"Ambriovi\u0107-Ristov","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2018.08.012_bib0020","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1517\/14712598.2015.993374","article-title":"Adenoviruses as gene\/vaccine delivery vectors: promises and pitfalls","volume":"15","author":"Appaiahgari","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0025","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.2174\/138920112800958823","article-title":"Mining the adenovirus \u201cVirome\u201d for systemic oncolytics","volume":"13","author":"Barry","year":"2011","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0030","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1099\/vir.0.81889-0","article-title":"Role of the putative heparan sulfate glycosaminoglycan-binding site of the adenovirus type 5 fiber shaft on liver detargeting and knob-mediated retargeting","volume":"87","author":"Bayo-Puxan","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0035","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1089\/hum.2009.038","article-title":"Replacement of adenovirus type 5 fiber shaft heparan sulfate proteoglycan-binding domain with RGD for improved tumor infectivity and targeting","volume":"20","author":"Bayo-Puxan","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0040","doi-asserted-by":"crossref","first-page":"8621","DOI":"10.1128\/JVI.76.17.8621-8631.2002","article-title":"Modulation of adenovirus vector tropism via incorporation of polypeptide ligands into the fiber protein","volume":"76","author":"Belousova","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0045","doi-asserted-by":"crossref","first-page":"11367","DOI":"10.1128\/JVI.77.21.11367-11377.2003","article-title":"Genetically targeted adenovirus vector directed to CD40-expressing cells","volume":"77","author":"Belousova","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0050","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/sj.cgt.7700806","article-title":"Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors","volume":"12","author":"Borovjagin","year":"2005","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0055","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.virol.2006.01.032","article-title":"Comparison of adenovirus fiber, protein IX, and hexon capsomeres as scaffolds for vector purification and cell targeting","volume":"349","author":"Campos","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2018.08.012_bib0060","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.3390\/v2102290","article-title":"Tropism-modification strategies for targeted gene delivery using adenoviral vectors","volume":"2","author":"Coughlan","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2018.08.012_bib0065","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/gt.2008.26","article-title":"Adenovirus targeting to HLA-A1\/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX","volume":"15","author":"de Vrij","year":"2008","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.virol.2010.10.040","article-title":"Enhanced transduction of CAR-negative cells by protein IX-gene deleted adenovirus 5 vectors","volume":"410","author":"de Vrij","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2018.08.012_bib0075","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/gt.2011.162","article-title":"A cathepsin-cleavage site between the adenovirus capsid protein IX and a tumor-targeting ligand improves targeted transduction","volume":"19","author":"de Vrij","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0080","doi-asserted-by":"crossref","first-page":"12249","DOI":"10.1128\/JVI.01584-07","article-title":"Fiber Shaft-Chimeric Adenovirus Vectors Lacking the KKTK Motif Efficiently Infect Liver Cells In Vivo","volume":"81","author":"Di Paolo","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0085","doi-asserted-by":"crossref","first-page":"6893","DOI":"10.1128\/JVI.76.14.6893-6899.2002","article-title":"Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX","volume":"76","author":"Dmitriev","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0145272","article-title":"A multi targeting conditionally replicating adenovirus displays enhanced oncolysis while maintaining expression of immunotherapeutic agents","volume":"10","author":"Dobbins","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2018.08.012_bib0095","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/gt.2016.32","article-title":"The relevance of coagulation factor X protection of adenoviruses in human sera","volume":"23","author":"Duffy","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0100","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/v10010020","article-title":"Blood coagulation factor X exerts differential effects on adenovirus entry into human lymphocytes","volume":"10","author":"Findlay","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2018.08.012_bib0105","first-page":"26","article-title":"Therapeutic efficacy of an oncolytic adenovirus containing RGD ligand in minor capsid protein IX and Fiber, \u039424DoubleRGD, in an ovarian cancer model","volume":"1","author":"Gamble","year":"2012","journal-title":"J. Mol. Biochem."},{"key":"10.1016\/j.virusres.2018.08.012_bib0110","doi-asserted-by":"crossref","first-page":"95","DOI":"10.32607\/20758251-2014-6-2-95-105","article-title":"Construction of a pIX-modified adenovirus vector able to effectively bind to nanoantibodies for targeting","volume":"6","author":"Garas","year":"2014","journal-title":"Acta Nat."},{"key":"10.1016\/j.virusres.2018.08.012_bib0115","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1158\/1535-7163.MCT-07-0176","article-title":"Treatment of metastatic renal cancer with capsid-modified oncolytic adenoviruses","volume":"6","author":"Guse","year":"2007","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0120","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1099\/jgv.0.000968","article-title":"Three novel, multiple recombinant types of species of human mastadenovirus D (HAdV-D 73, 74 & 75) isolated from diarrhoeal faeces of immunocompromised patients","volume":"98","author":"Hage","year":"2017","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0125","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/15419061.2013.855204","article-title":"Structural and functional diversity of Desmosomes","volume":"20","author":"Harmon","year":"2013","journal-title":"Cell Commun. Adhes."},{"key":"10.1016\/j.virusres.2018.08.012_bib0130","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jconrel.2014.07.008","article-title":"A genetic fiber modification to achieve matrix-metalloprotease-activated infectivity of oncolytic adenovirus","volume":"192","author":"Jos\u00e9","year":"2014","journal-title":"J. Control. Release"},{"key":"10.1016\/j.virusres.2018.08.012_bib0135","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.bbrc.2005.01.080","article-title":"Improved gene delivery into neuroglial cells using a fiber-modified adenovirus vector","volume":"328","author":"Joung","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virusres.2018.08.012_bib0140","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/labinvest.2014.82","article-title":"Adenoviral targeting using genetically incorporated camelid single variable domains","volume":"94","author":"Kaliberov","year":"2014","journal-title":"Lab. Invest."},{"key":"10.1016\/j.virusres.2018.08.012_bib0145","first-page":"275","article-title":"Targeting adenovirus to the serotype 3 receptor increases gene transfer efficiency to ovarian cancer cells","volume":"8","author":"Kanerva","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.virusres.2018.08.012_bib0150","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1089\/hum.2015.008","article-title":"A genetically modified adenoviral vector with a phage display-derived peptide incorporated into Fiber fibritin chimera prolongs survival in experimental glioma","volume":"26","author":"Kim","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0155","doi-asserted-by":"crossref","first-page":"9508","DOI":"10.1128\/JVI.73.11.9508-9514.1999","article-title":"Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR","volume":"73","author":"Kirby","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0160","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1128\/JVI.74.6.2804-2813.2000","article-title":"Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein","volume":"74","author":"Kirby","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0165","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.placenta.2004.10.010","article-title":"Comparison of transgene expression mediated by several Fiber-modified adenovirus vectors in trophoblast cells","volume":"26","author":"Koizumi","year":"2005","journal-title":"Placenta"},{"key":"10.1016\/j.virusres.2018.08.012_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060032","article-title":"Mutation of the fiber shaft heparan sulphate binding site of a 5\/3 chimeric adenovirus reduces liver tropism","volume":"8","author":"Koski","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2018.08.012_bib0175","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.1128\/JVI.75.9.4176-4183.2001","article-title":"Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin","volume":"75","author":"Krasnykh","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0180","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/sj.gt.3302859","article-title":"Characterization of capsid-modified adenovirus vectors containing heterologous peptides in the fiber knob, protein IX, or hexon","volume":"14","author":"Kurachi","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0185","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/sj.gt.3302969","article-title":"Fiber-modified adenovirus vectors containing the TAT peptide derived from HIV-1 in the fiber knob have efficient gene transfer activity","volume":"14","author":"Kurachi","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0190","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1162\/1535350041464874","article-title":"Fluorescently labeled adenovirus with pIX-EGFP for vector detection","volume":"3","author":"Le","year":"2004","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.virusres.2018.08.012_bib0195","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/jnci\/djj022","article-title":"Dynamic monitoring of oncolytic adenovirus in vivo by genetic capsid labeling","volume":"98","author":"Le","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.virusres.2018.08.012_bib0200","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/gt.2012.39","article-title":"Sstr2A: a relevant target for the delivery of genes into human glioblastoma cells using fiber-modified adenoviral vectors","volume":"20","author":"L\u00e9colle","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.gendis.2017.04.001","article-title":"Adenovirus-mediated gene delivery: potential applications for gene and cell-based therapies in the new era of personalized medicine","volume":"4","author":"Lee","year":"2017","journal-title":"Genes Dis."},{"key":"10.1016\/j.virusres.2018.08.012_bib0210","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.virol.2005.04.005","article-title":"Genetic incorporation of HSV-1 thymidine kinase into the adenovirus protein IX for functional display on the virion","volume":"338","author":"Li","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2018.08.012_bib0215","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1128\/CMR.00116-13","article-title":"Adenovirus infections in immunocompetent and immunocompromised patients","volume":"27","author":"Lion","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.virusres.2018.08.012_bib0220","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1126\/science.1187433","article-title":"Atomic structure of human adenovirus by Cryo-EM reveals interactions among protein networks","volume":"329","author":"Liu","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.virusres.2018.08.012_bib0225","doi-asserted-by":"crossref","DOI":"10.2310\/7290.2014.00022","article-title":"Construction and radiolabeling of adenovirus variants that incorporate human metallothionein into protein IX for analysis of biodistribution","volume":"13","author":"Liu","year":"2014","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.virusres.2018.08.012_bib0230","doi-asserted-by":"crossref","first-page":"e02487","DOI":"10.1128\/JVI.02487-16","article-title":"Defining a novel role for the coxsackievirus and adenovirus receptor in human adenovirus serotype 5 transduction in vitro in the presence of mouse serum","volume":"91","author":"Lopez-Gordo","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117254","article-title":"Hexon modification to improve the activity of oncolytic adenovirus vectors against neoplastic and stromal cells in pancreatic cancer","volume":"10","author":"Lucas","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2018.08.012_bib0240","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.1128\/JVI.71.7.5102-5109.1997","article-title":"The product of the adenovirus intermediate gene IX is a transcriptional activator","volume":"71","author":"Lutz","year":"1997","journal-title":"J. Virol."},{"issue":"148","key":"10.1016\/j.virusres.2018.08.012_bib0245","article-title":"Integrin \u03b1v\u03b25 is a primary receptor for adenovirus in CAR-negative cells","volume":"7","author":"Lyle","year":"2010","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2018.08.012_bib0250","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/cgt.2012.79","article-title":"HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice","volume":"19","author":"MacLeod","year":"2012","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0255","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.bbrc.2006.07.051","article-title":"Disulfide bond formation in NGR fiber-modified adenovirus is essential for retargeting to aminopeptidase N","volume":"348","author":"Majhen","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virusres.2018.08.012_bib0260","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.virusres.2008.10.004","article-title":"Differential role of \u03b1v\u03b23 and \u03b1v\u03b25 integrins in internalization and transduction efficacies of wild type and RGD4C fiber-modified adenoviruses","volume":"139","author":"Majhen","year":"2009","journal-title":"Virus Res."},{"key":"10.1016\/j.virusres.2018.08.012_bib0265","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/jgm.2686","article-title":"The disulfide bond of an RGD4C motif inserted within the Hi loop of the adenovirus type 5 fiber protein is critical for retargeting to \u03b1 v -integrins","volume":"14","author":"Majhen","year":"2012","journal-title":"J. Gene Med."},{"key":"10.1016\/j.virusres.2018.08.012_bib0270","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/1535-7163.MCT-17-0671","article-title":"The novel oncolytic adenoviral mutant Ad5-3\u0394-A20T retargeted to \u03b1v\u03b26 integrins efficiently eliminates pancreatic cancer cells","volume":"17","author":"Man","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0275","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/gt.2009.65","article-title":"Development of fiber-substituted adenovirus vectors containing foreign peptides in the adenovirus serotype 35 fiber knob","volume":"16","author":"Matsui","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0280","doi-asserted-by":"crossref","first-page":"4191","DOI":"10.1016\/j.biomaterials.2013.02.046","article-title":"A targeted adenovirus vector displaying a human fibronectin type III domain-based monobody in a fiber protein","volume":"34","author":"Matsui","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.virusres.2018.08.012_bib0285","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/mp100214b","article-title":"Capsid-incorporation of antigens into adenovirus capsid proteins for a vaccine approach","volume":"8","author":"Matthews","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.virusres.2018.08.012_bib0290","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2310\/7290.2006.00029","article-title":"Genetic incorporation of a herpes simplex virus type 1 thymidine kinase and firefly luciferase fusion into the adenovirus protein IX for functional display on the virion","volume":"5","author":"Matthews","year":"2006","journal-title":"Mol. Imaging"},{"key":"10.1016\/j.virusres.2018.08.012_bib0295","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1743-422X-5-98","article-title":"Optimization of capsid-incorporated antigens for a novel adenovirus vaccine approach","volume":"5","author":"Matthews","year":"2008","journal-title":"Virol. J."},{"key":"10.1016\/j.virusres.2018.08.012_bib0300","doi-asserted-by":"crossref","first-page":"5361","DOI":"10.1128\/JVI.00256-06","article-title":"Characterization of a permissive epitope insertion site in adenovirus hexon","volume":"80","author":"McConnell","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0305","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ymthe.2004.01.012","article-title":"Use of adenovirus protein IX (pIX) to display large polypeptides on the virion\u2014generation of fluorescent virus through the incorporation of pIX-GFP","volume":"9","author":"Meulenbroek","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0310","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/sj.gt.3303007","article-title":"Direct selection of targeted adenovirus vectors by random peptide display on the fiber knob","volume":"14","author":"Miura","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0315","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/mt.2012.205","article-title":"Infectivity-selective oncolytic adenovirus developed by high-throughput screening of adenovirus-formatted library","volume":"21","author":"Miura","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0320","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/jgm.1385","article-title":"A chimeric adenovirus with an Ad 3 fiber knob modification augments glioma virotherapy","volume":"11","author":"Nandi","year":"2009","journal-title":"J. Gene Med."},{"key":"10.1016\/j.virusres.2018.08.012_bib0325","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3390\/v8120337","article-title":"Insights into adenovirus uncoating from interactions with integrins and mediators of host immunity","volume":"8","author":"Nemerow","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2018.08.012_bib0330","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1006\/mthe.2001.0489","article-title":"Ablating adenovirus type 5 fiber-CAR binding and HI loop insertion of the SIGYPLP peptide generate an endothelial cell-selective adenovirus","volume":"4","author":"Nicklin","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0335","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ymthe.2005.05.008","article-title":"The influence of adenovirus fiber structure and function on vector development for gene therapy","volume":"12","author":"Nicklin","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0340","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/gt.2009.1","article-title":"Oncolytic virus therapy for pancreatic cancer using the adenovirus library displaying random peptides on the fiber knob","volume":"16","author":"Nishimoto","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0345","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045550","article-title":"Development of peritoneal tumor-targeting vector by in vivo screening with a random peptide-displaying adenovirus library","volume":"7","author":"Nishimoto","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2018.08.012_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2017.05.025","article-title":"CAR: a key regulator of adhesion and inflammation","volume":"89","author":"Ortiz-Zapater","year":"2017","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0355","doi-asserted-by":"crossref","first-page":"89391","DOI":"10.18632\/oncotarget.20810","article-title":"Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma","volume":"8","author":"Panek","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.virusres.2018.08.012_bib0360","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1021\/mp100219n","article-title":"Oncolytic adenoviruses for the treatment of human cancer: focus on translational and clinical data","volume":"8","author":"Pesonen","year":"2011","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.virusres.2018.08.012_bib0365","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/cgt.2008.75","article-title":"Oncolytic adenovirus retargeted to Delta-EGFR induces selective antiglioma activity","volume":"16","author":"Piao","year":"2009","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0370","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.virol.2011.09.004","article-title":"Use of Cre\/loxP recombination to swap cell binding motifs on the adenoviral capsid protein IX","volume":"420","author":"Poulin","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2018.08.012_bib0375","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2174\/1875037000801010007","article-title":"Enhanced gene delivery to human primary endothelial cells using tropism-modified adenovirus vectors","volume":"1","author":"Preuss","year":"2008","journal-title":"Open Gene Ther. J."},{"key":"10.1016\/j.virusres.2018.08.012_bib0380","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1126\/science.1187292","article-title":"Crystal structure of human adenovirus at 3.5 a resolution","volume":"329","author":"Reddy","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.virusres.2018.08.012_bib0385","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1038\/bjc.2013.509","article-title":"Presence of the coxsackievirus and adenovirus receptor (CAR) in human neoplasms: a multitumour array analysis","volume":"109","author":"Reeh","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.virusres.2018.08.012_bib0390","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.3390\/v6041540","article-title":"Peptide-based technologies to alter adenoviral vector tropism: ways and means for systemic treatment of cancer","volume":"6","author":"Reetz","year":"2014","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2018.08.012_bib0395","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1002\/ijc.20295","article-title":"Gene transfer to cervical cancer with fiber-modified adenoviruses","volume":"111","author":"Rein","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.virusres.2018.08.012_bib0400","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1099\/jgv.0.000505","article-title":"Retargeting FX-binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loop","volume":"97","author":"Robertson","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0405","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1126\/science.286.5444.1568","article-title":"Identification of a conserved receptor-binding site on the fiber proteins of CAR-recognizing adenoviridae","volume":"286","author":"Roelvink","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.virusres.2018.08.012_bib0410","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/gt.2011.106","article-title":"Improved systemic antitumor therapy with oncolytic adenoviruses by replacing the fiber shaft HSG-binding domain with RGD","volume":"19","author":"Rojas","year":"2012","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0415","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.1128\/JVI.75.15.7131-7141.2001","article-title":"Functional analysis of adenovirus protein IX identifies domains involved in capsid stability, transcriptional activity, and nuclear reorganization","volume":"75","author":"Rosa-Calatrava","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0420","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.embor.embor943","article-title":"Adenovirus protein IX sequesters host-cell promyelocytic leukaemia protein and contributes to efficient viral proliferation","volume":"4","author":"Rosa-Calatrava","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.virusres.2018.08.012_bib0425","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.coviro.2016.06.009","article-title":"Recent advances in oncolytic adenovirus therapies for cancer","volume":"21","author":"Rosewell Shaw","year":"2016","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0430","doi-asserted-by":"crossref","first-page":"9553","DOI":"10.1128\/JVI.77.17.9553-9566.2003","article-title":"Structural and phylogenetic analysis of adenovirus hexons by use of high-resolution x-ray crystallographic, molecular modeling, and sequence-based methods","volume":"77","author":"Rux","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0435","first-page":"119","article-title":"Characterization of an oncolytic adenovirus vector constructed to target the cMet receptor","volume":"4","author":"Sakr","year":"2015","journal-title":"Oncolytic Virother."},{"key":"10.1016\/j.virusres.2018.08.012_bib0440","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1248\/bpb.31.1819","article-title":"Development and evaluation of a novel gene delivery vehicle composed of adenovirus serotype 35","volume":"31","author":"Sakurai","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.virusres.2018.08.012_bib0445","doi-asserted-by":"crossref","first-page":"5032","DOI":"10.1128\/JVI.78.10.5032-5037.2004","article-title":"Activation of adenoviral gene expression by protein IX is not required for efficient virus replication","volume":"78","author":"Sargent","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0450","doi-asserted-by":"crossref","first-page":"76044","DOI":"10.18632\/oncotarget.18340","article-title":"CD133-targeted oncolytic adenovirus demonstrates anti-tumor effect in colorectal cancer","volume":"8","author":"Sato-Dahlman","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.virusres.2018.08.012_bib0455","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/sj.gt.3301815","article-title":"Fiber shaft extension in combination with HI loop ligands augments infectivity for CAR-negative tumor targets but does not enhance hepatotropism in vivo","volume":"9","author":"Seki","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0460","doi-asserted-by":"crossref","first-page":"10274","DOI":"10.1128\/JVI.74.22.10274-10286.2000","article-title":"Dependence of adenovirus infectivity on length of the fiber shaft domain","volume":"74","author":"Shayakhmetov","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0465","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/JVI.79.2.1053-1061.2005","article-title":"Deletion of penton RGD motifs affects the efficiency of both the internalization and the endosome escape of viral particles containing adenovirus serotype 5 or 35 Fiber knobs","volume":"79","author":"Shayakhmetov","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0470","doi-asserted-by":"crossref","first-page":"E19","DOI":"10.3171\/foc.2006.20.4.1","article-title":"Oncolytic adenoviral therapy for glioblastoma multiforme","volume":"20","author":"Sonabend","year":"2006","journal-title":"Neurosurg. Focus"},{"key":"10.1016\/j.virusres.2018.08.012_bib0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2018.08.069","article-title":"A compendium of adenovirus genetic modifications for enhanced replication, oncolysis, and tumor immunosurveillance in cancer therapy","author":"Stepanenko","year":"2018","journal-title":"Gene"},{"key":"10.1016\/j.virusres.2018.08.012_bib0480","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006914","article-title":"Lung macrophage scavenger receptor SR-A6 (MARCO) is an adenovirus type-specific virus entry receptor","volume":"14","author":"Stichling","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virusres.2018.08.012_bib0485","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1743-6109.2006.00168.x","article-title":"Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds","volume":"14","author":"Stoff","year":"2006","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.virusres.2018.08.012_bib0490","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.4161\/cbt.4.11.2084","article-title":"Gene transfer to carcinoma of the breast with fiber-modified adenoviral vectors in a tissue slice model system","volume":"4","author":"Stoff-Khalili","year":"2005","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0495","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1038\/sj.mt.6300319","article-title":"Comparison of adenoviruses from species B, C, E, and F after intravenous delivery","volume":"15","author":"Stone","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0500","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0042-6822(03)00067-9","article-title":"A mosaic adenovirus possessing serotype Ad5 and serotype Ad3 knobs exhibits expanded tropism","volume":"309","author":"Takayama","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.virusres.2018.08.012_bib0505","doi-asserted-by":"crossref","first-page":"e8526","DOI":"10.1371\/journal.pone.0008526","article-title":"Derivation of a triple mosaic adenovirus for cancer gene therapy","volume":"4","author":"Tang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.virusres.2018.08.012_bib0510","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.3390\/v2091844","article-title":"Increasing the efficacy of oncolytic adenovirus vectors","volume":"2","author":"Toth","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.virusres.2018.08.012_bib0515","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/JVI.06181-11","article-title":"Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection","volume":"86","author":"Trinh","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0520","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbrc.2005.07.054","article-title":"Reovirus \u03c31 fiber incorporated into adenovirus serotype 5 enhances infectivity via a CAR-independent pathway","volume":"335","author":"Tsuruta","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virusres.2018.08.012_bib0525","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1158\/1078-0432.CCR-06-2706","article-title":"A mosaic fiber adenovirus serotype 5 vector containing reovirus sigma 1 and adenovirus serotype 3 knob fibers increases transduction in an ovarian cancer ex vivo system via a coxsackie and adenovirus receptor-independent pathway","volume":"13","author":"Tsuruta","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.virusres.2018.08.012_bib0530","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1158\/1535-7163.MCT-06-0187","article-title":"Enhanced transduction of malignant glioma with a double targeted Ad5\/3-RGD fiber-modified adenovirus","volume":"5","author":"Tyler","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0535","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1089\/hum.2006.146","article-title":"Novel recombinant adenoviral vector that targets the interleukin-13 receptor alpha2 chain permits effective gene transfer to malignant glioma","volume":"18","author":"Ulasov","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0540","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1089\/hum.2007.002","article-title":"Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma","volume":"18","author":"Ulasov","year":"2007","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0545","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.gendis.2014.09.009","article-title":"Oncolytic adenoviruses: a thorny path to glioma cure","volume":"1","author":"Ulasov","year":"2014","journal-title":"Genes Dis."},{"key":"10.1016\/j.virusres.2018.08.012_bib0550","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1089\/hum.2015.015","article-title":"Incorporation of peptides targeting EGFR and FGFR1 into the adenoviral Fiber knob domain and their evaluation as targeted Cancer therapies","volume":"26","author":"Uusi-Kerttula","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0555","article-title":"Ad5NULL-A20 - a tropism-modified, \u03b1v\u03b26 integrin-selective oncolytic adenovirus for epithelial ovarian cancer therapies","volume":"2018","author":"Uusi-Kerttula","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.virusres.2018.08.012_bib0560","first-page":"233","article-title":"A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancer","volume":"36","author":"Van Geer","year":"2010","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0565","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/JVI.78.7.3470-3479.2004","article-title":"Spacers increase the accessibility of peptide ligands linked to the carboxyl terminus of adenovirus minor capsid protein IX","volume":"78","author":"Vellinga","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0570","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/sj.gt.3302908","article-title":"Efficient incorporation of a functional hyper-stable single-chain antibody fragment protein-IX fusion in the adenovirus capsid","volume":"14","author":"Vellinga","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0575","doi-asserted-by":"crossref","first-page":"5156","DOI":"10.1128\/JVI.73.6.5156-5161.1999","article-title":"RGD inclusion in the hexon monomer provides adenovirus type 5-based vectors with a fiber knob-independent pathway for infection","volume":"73","author":"Vigne","year":"1999","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0580","doi-asserted-by":"crossref","first-page":"511","DOI":"10.4161\/cbt.2.5.440","article-title":"Enhanced adenovirus infection of melanoma cells by fiber-modification: incorporation of RGD peptide or Ad5\/3 chimerism","volume":"2","author":"Volk","year":"2003","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0585","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2008.01.016","article-title":"Adenovirus serotype 5 hexon mediates liver gene transfer","volume":"132","author":"Waddington","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.virusres.2018.08.012_bib0590","doi-asserted-by":"crossref","first-page":"12785","DOI":"10.1128\/JVI.01732-07","article-title":"Identification of CD46 binding sites within the adenovirus serotype 35 Fiber knob","volume":"81","author":"Wang","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0595","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nm.2270","article-title":"Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14","volume":"17","author":"Wang","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2018.08.012_bib0600","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1128\/JVI.01825-13","article-title":"Structural and functional studies on the interaction of adenovirus fiber knobs and desmoglein 2","volume":"87","author":"Wang","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0605","article-title":"A novel capsid-modified oncolytic recombinant adenovirus type 5 for tumor-targeting gene therapy by intravenous route","author":"Wang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.virusres.2018.08.012_bib0610","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ymthe.2003.11.006","article-title":"Development of efficient viral vectors selective for vascular smooth muscle cells","volume":"9","author":"Work","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0615","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1089\/10430340260201734","article-title":"Double modification of adenovirus fiber with RGD and polylysine motifs improves coxsackievirus-adenovirus receptor-independent gene transfer efficiency","volume":"13","author":"Wu","year":"2002","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0620","doi-asserted-by":"crossref","first-page":"7225","DOI":"10.1128\/JVI.77.13.7225-7235.2003","article-title":"Flexibility of the adenovirus fiber is required for efficient receptor interaction","volume":"77","author":"Wu","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0625","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1128\/JVI.79.6.3382-3390.2005","article-title":"Identification of sites in adenovirus hexon for foreign peptide incorporation","volume":"79","author":"Wu","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0630","doi-asserted-by":"crossref","first-page":"9549","DOI":"10.1158\/0008-5472.CAN-10-1760","article-title":"Adenovirus targeting to prostate-specific membrane antigen through virus-displayed, semirandom peptide library screening","volume":"70","author":"Wu","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.virusres.2018.08.012_bib0635","doi-asserted-by":"crossref","first-page":"11359","DOI":"10.1128\/JVI.74.23.11359-11366.2000","article-title":"Recombinant human adenovirus: targeting to the human transferrin receptor improves gene transfer to brain microcapillary endothelium","volume":"74","author":"Xia","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0640","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/nm.3107","article-title":"Coagulation factor X shields adenovirus type 5 from attack by natural antibodies and complement","volume":"19","author":"Xu","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.virusres.2018.08.012_bib0645","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/15384047.2017.1395115","article-title":"A novel fiber chimeric conditionally replicative adenovirus-Ad5\/F35 for tumor therapy","volume":"18","author":"Yang","year":"2017","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0650","doi-asserted-by":"crossref","first-page":"34875","DOI":"10.18632\/oncotarget.5332","article-title":"A vesicular stomatitis virus glycoprotein epitope-incorporated oncolytic adenovirus overcomes CAR-dependency and shows markedly enhanced cancer cell killing and suppression of tumor growth","volume":"6","author":"Yoon","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.virusres.2018.08.012_bib0655","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/17425247.2016.1158707","article-title":"Redirecting adenovirus tropism by genetic, chemical, and mechanical modification of the adenovirus surface for cancer gene therapy","volume":"13","author":"Yoon","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.virusres.2018.08.012_bib0660","doi-asserted-by":"crossref","first-page":"13114","DOI":"10.1128\/JVI.05759-11","article-title":"Adenovirus with Hexon Tat-Protein transduction domain modification exhibits increased therapeutic effect in experimental neuroblastoma and neuroendocrine tumors","volume":"85","author":"Yu","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0665","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1089\/104303403322542284","article-title":"Dl-VSVG-LacZ, a vesicular stomatitis virus glycoprotein epitope-incorporated adenovirus, exhibits marked enhancement in gene transduction efficiency","volume":"14","author":"Yun","year":"2003","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.virusres.2018.08.012_bib0670","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/JVI.01939-15","article-title":"Hepatocyte heparan sulfate is required for adeno-associated virus 2 but dispensable for adenovirus 5 liver transduction in vivo","volume":"90","author":"Zaiss","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.virusres.2018.08.012_bib0675","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s11262-017-1487-2","article-title":"Getting genetic access to natural adenovirus genomes to explore vector diversity","volume":"53","author":"Zhang","year":"2017","journal-title":"Virus Genes"}],"container-title":["Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218304131?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168170218304131?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,7]],"date-time":"2020-11-07T23:17:52Z","timestamp":1604791072000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168170218304131"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":135,"alternative-id":["S0168170218304131"],"URL":"https:\/\/doi.org\/10.1016\/j.virusres.2018.08.012","relation":{},"ISSN":["0168-1702"],"issn-type":[{"value":"0168-1702","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tropism and transduction of oncolytic adenovirus 5 vectors in cancer therapy: Focus on fiber chimerism and mosaicism, hexon and pIX","name":"articletitle","label":"Article Title"},{"value":"Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virusres.2018.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}